par
Gus Iversen, Editor in Chief | January 07, 2026
RWJBarnabas Health and Englewood Health have signed a definitive agreement that would bring Englewood under the umbrella of New Jersey’s largest academic health system.
The move, pending approval from state and federal regulators, would expand RWJBarnabas Health’s presence in northern New Jersey, particularly in Bergen, Hudson, and Passaic counties.
Under the terms of the agreement, the West Orange-based RWJBarnabas Health would make capital investments in Englewood Health, with plans to expand its outpatient services and community health programs. Executives from both organizations said the integration would aim to increase access to care and enhance service delivery.

Ad Statistics
Times Displayed: 357
Times Visited: 1 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.
“Englewood Health has a long history of providing superior care to the residents of Bergen County and surrounding communities,” said Mark E. Manigan, president and CEO of RWJBarnabas Health. “We look to build upon this history together to enhance access to world-class academic medicine and cutting-edge cancer treatment, as well as expand community programs and vital resources for the most vulnerable.”
Englewood Health, based in Englewood, operates a 289-bed acute care hospital and a network of over 800 providers across northern New Jersey. It has received recognition from Leapfrog, U.S. News & World Report, and Newsweek for patient safety and clinical quality.
“This transaction will ensure Englewood Health’s ability to deliver world-class care to the communities we serve in a broader way, with greater resources and more cutting-edge technologies,” said Warren Geller, president and CEO of Englewood Health.
RWJBarnabas Health’s system includes 14 hospitals and more than 700 patient care locations. It also partners with Rutgers University to operate the state’s only NCI-designated Comprehensive Cancer Center.
The organizations did not disclose a timeline for closing the transaction, which remains subject to regulatory review.